Biotech company Systemic Bio officials announced the opening of its new headquarters at the Texas Medical Center Innovation Factory at 2450 Holcombe Blvd., Houston.
“The opening of this facility is a fantastic milestone in Systemic Bio’s journey to accelerate drug discovery and development and a leap forward for the field of bio printing,” CEO Taci Pereira said in a news release.
The 15,000 square feet of office space will house the company’s research and development teams, engineers and scientists at the new laboratory, according to the news release. The state-of-the-art facility contains a cleanroom for bio printed hydrogel production, which is part of the company’s mission to accelerate pharmaceutical drug discovery and development.
These proprietary organs-on-chips can be manufactured in large quantities and then perfused with drugs to study the effects on healthy or diseased tissue at the earliest stages of pharmaceutical drug development. Their systems have the potential to significantly reduce both the high costs and extended times required for pharmaceutical companies to bring new drugs to market, the announcement stated.
“This marks a pivotal shift for bioprinting, going from experimental research to full-scale production,” Pereira said.